Test Bank for Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics, 8th Edition by Rifai, Horvath, and Wittwer

Test bank for Tietz Fundamentals of Clinical Chemistryand
I I I I I I




Molecular Diagnostics,
I I




8th Edition by Nader Rifai, PhD
I I I I I I




Chapters 1 - 49I I I I

,TietzIFundamentalsIofIClinicalIChemistryIandIMolecularIDiagnosticsI8thI EditionITestIBank

TableIofIcontents:
I.IPrinciplesIOfILaboratoryIMedicine
ChapterI1.IClinicalIChemistry,IMolecularIDiagnostics,IandILaboratoryIMedicine
ChapterI2.ISelectionIandIAnalyticalIEvaluationIofIMethodsI—IWithIStatisticalITechniques
ChapterI3.IClinicalIEvaluationIofIMethods
ChapterI4.IEvidence-BasedILaboratoryIMedicine
ChapterI5.IEstablishmentIandIUseIofIReferenceIValues
ChapterI6.ISpecimenICollection,IProcessing,IandIOtherIPreanalyticalIVariables
ChapterI7.IQualityIManagement
II.IAnalyticalITechniquesIAndIInstrumentation
ChapterI8.IPrinciplesIofIBasicITechniquesIandILaboratoryISafety
ChapterI9.IOpticalITechniques
ChapterI10.IElectrochemistryIandIChemicalISensors
ChapterI11.IElectrophoresis
ChapterI12.IChromatography
ChapterI13.IMassISpectrometry
ChapterI14.IEnzymeIandIRateIAnalyses
ChapterI15.IImmunochemicalITechniques
ChapterI16IAutomation
ChapterI17.IPoint-of-CareIInstrumentation
III.I Analytes
ChapterI18.IAminoIAcids,IPeptides,IandIProteins
ChapterI19.ISerumIEnzymes
ChapterI20.ITumorIMarkersIandICancerIGenes
ChapterI21.IKidneyIFunctionITestsI—ICreatinine,IGFR,IUrea,IandIUricIAcid
ChapterI22.ICarbohydrates
ChapterI23.ILipids,ILipoproteins,IApolipoproteins,IandIOtherICardiacIRiskIFactors
ChapterI24.IElectrolytesIandIBloodIGases
ChapterI25.IHormones
ChapterI26.I CatecholaminesIandISerotonin
ChapterI27.I Vitamins,ITraceIElements,INutritionalIAssessment
ChapterI28.IHemoglobin,IIron,IandIBilirubin
ChapterI29.IPorphyrinsIandIPorphyrias
ChapterI30.ITherapeuticIDrugsIandITheirIManagement
ChapterI31.IClinicalIToxicology
ChapterI32.I ToxicIMetals
IV.I Pathophysiology
ChapterI33.IDiabetes

,ChapterI34.I CardiovascularIDisease
ChapterI35.IKidneyIDisease
ChapterI36.I PhysiologyIandIDisordersIofIWater,IElectrolyte,IandIAcid-BaseIMetabolism
ChapterI37.IILiverIDisease
ChapterI38.I GastrointestinalIandIPancreaticIDiseases
ChapterI39.IIDisordersIofIBoneIandIMineralIMetabolism
ChapterI40.IIDisordersIofItheIPituitaryIGland
ChapterI41.I DisordersIofItheIAdrenalICortex
ChapterI42.I ThyroidIDisorders
ChapterI43.I Reproduction-RelatedIDisorders
ChapterI44.IIPregnancyIandIPrenatalITesting
ChapterI45.I NewbornIScreeningIandIInbornIErrorsIofIMetabolism
ChapterI46.IPharmacogenetics
V.I MolecularIDiagnostics
ChapterI47.IPrinciplesIofIMolecularIBiology
ChapterI48.INucleicIAcidITechniquesIandIApplications
ChapterI49.IGenomesIandINucleicIAcidIAlterations

, ChapterI01:IClinicalIChemistry,IMolecularIDiagnostics,IandILaboratoryIMedicineITestIBank


MULTIPLEICHOICE

1. AnIindividualIworkingIinIaIclinicalIchemistryIlaboratoryIisImarriedItoIaIsalesIrepresentativeIwhoI
worksIforIaIcompanyIthatIsellsIchemistryIlaboratoryIsupplies.IWhenItheIlaboratoryImanager
requestsIaIlistIofIneededIsupplies,IcostIofIsupplies,IandIvendors,IthisIindividualIonlyIrecommend
s theIspouse’sIcompanyIasItheIvendor.IThisIisIconsideredItoIbeIa(n):
a. accountingIissue.
b. possibleIconflictIofIinterest.
c. maintenanceIofIconfidentialityIissue.
d. problemIwithIresourceIallocation.

ANS:I B
ConcernIhasIbeenIraisedIoverItheIinterrelationshipsIbetweenIpractitionersIinItheImedicalIfieldIa
ndIcommercialIsuppliersIofIdrugs,Idevices,Iequipment,Ietc.,ItoItheImedicalIprofession.
Similarly,IrelationshipsIhaveIbeenIscrutinizedIbetweenIclinicalIlaboratoriansIandImanufacturersI
andIprovidersIofIdiagnosticIequipmentIandIsupplies.ITheseIconcernsIledItheINationalIInstitutesIo
fIHealthI(NIH)IinI1995ItoIrequireIofficialIinstitutionalIreviewIofIfinancialIdisclosureIbyIresearchersI
andImanagementIofIsituationsIinIwhichIdisclosureIindicatesIpotentialIconflictsIofIinterest.

DIF: 1 REF:IIIPageI4-5 OBJ:I 6I|I7

2. AIpatientIvisitsIherIphysicianIstatingIthatIherIprescribedIpainkillerIisInotIworkingItoIreduceItheI
painIfollowingIherIrecentIsurgery.IAIfriendIofItheIpatientIclaimsIthatItheIsameIpainkiller
“workedIwonders”ItoIreduceIherIpainIafterItheIsameIsurgery.ITheIphysicianIstatesIthatIthe
differenceIinItheIeffectIofItheIdrugImightIbeIcausedIby
,IwhichIisIstudiedIinIpharmacogenetics.
a. epidemiology
b. anIinheritedIdisease
c. aIconflictIofIinterest
d. aIgeneticIvariationIinIdrug-metabolizingIenzymes
ANS:I D
PharmacogeneticsIisItheIstudyIofItheIgeneticIvariationIofIdrugImetabolismIbetweenIi
ndividuals.

DIF: 1 REF:IIIPageI3 OBJ:I 1

3. JohnIworksIinIaImolecularIdiagnosticsIlaboratoryIandIreceivesIaIbloodIsampleIthatIhasItheIna
meIofIaIcloseIfriendIprintedIonItheIbar-
codedIlabel.ITheIgeneticItestIthatIisIorderedIonItheIfriend’sIsampleIwouldIprovideIdiagnosticIi
nformationIaboutIaIdisorderIthatIhasIaIpoorIprognosis,IandItheItestIisIusuallyIperformedIbyIJo
hn.IHeIasksIaIfellowIemployeeItoIanalyzeItheIsampleIforIhimIandInotIdivulgeItheIresults.IThisIet
hicalIissueIconcerns:
a. confidentialityIofIpatientIgeneticIandImedicalIinformation.
b. aIconflictIofIinterest.
c. resourceIallocation.
d. diagnosticIaccuracy.